论文部分内容阅读
河北省科、河北省医药总公司于1985年6月29日在石家庄召开了恩氟烷(enflurane,安氟醚)鉴定会.有关单位的专家、技术人员共34人参加了会议.对恩氟烷的工艺路线、质量标准、临床试用病例进行了详细的讨论和审查.一致认为:全身吸入麻醉药的研制成功,填补了我国麻醉药的一项空白,且原料易得,合成工艺路线可行,经济合理,技术经济指标接近国外水平,质量标准是参照美国药典20版制定的.其中挥发性杂质的检测方法较美国药典更为先进而可靠.
Hebei Province Branch, Hebei Province Pharmaceutical Corporation held an enflurane (enflurane) appraisal meeting in Shijiazhuang on June 29, 1985. A total of 34 experts and technicians from relevant units attended the meeting. Alkane process route, quality standards, clinical trial cases were discussed in detail and agreed that: the successful development of systemic inhalation anesthetics, filling a blank of anesthetics in our country, and raw materials readily available, synthetic route feasible, Economic and reasonable, technical and economic indicators close to foreign standards, quality standards are based on reference to the United States Pharmacopoeia 20 version of which the detection of volatile impurities than the United States Pharmacopoeia more advanced and reliable.